Download PDF
CC BY-NC-ND 4.0 · Endosc Int Open 2020; 08(05): E607-E610
DOI: 10.1055/a-1127-2991
Innovation forum

First-in-man feasibility study of a novel ingestible magnetically inflated balloon capsule for treatment of obesity

Hung Leng Kaan
1   Department of General Surgery, National University Hospital, Singapore
,
Phuoc Thien Phan
2   School of Mechanical & Aerospace Engineering, Nanyang Technological University, Singapore
,
Anthony Meng Huat Tiong
2   School of Mechanical & Aerospace Engineering, Nanyang Technological University, Singapore
,
Muneaki Miyasaka
2   School of Mechanical & Aerospace Engineering, Nanyang Technological University, Singapore
,
Soo Jay Phee
2   School of Mechanical & Aerospace Engineering, Nanyang Technological University, Singapore
,
Khek Yu Ho
3   Department of Medicine, National University of Singapore
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Intragastric balloons (IGBs) are an established treatment option for obesity. Major barriers to dissemination of IGBs include lack of long-term efficacy outcomes, safety concerns, cost, and tolerability. We developed a novel ingestible magnetically inflated balloon capsule (IMI-BC) in hopes of overcoming these challenges. The IMI-BC is significantly cheaper than IGBs currently available on the market. We performed proof-of-concept animal studies and a first-in-human feasibility study to demonstrate the feasibility of inflating the IMI-BC using an external magnet. Further studies are currently being conducted to evaluate the safety, tolerability, and long-term efficacy of the IMI-BC. When fully developed, we anticipate that this device will benefit obese patients.



Publication History

Received: 19 June 2019

Accepted: 30 December 2019

Article published online:
17 April 2020

© 2020. Owner and Copyright ©

© Georg Thieme Verlag KG
Stuttgart · New York

Comment to this article:

Endoscopy International Open – recently publishedEndoscopy 2020; 52(06): 523-523
DOI: 10.1055/a-1121-0097

 

  • References

  • 1 Whitlock G, Lewington S, Sherliker P. et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373: 1083-1096
    CrossrefPubMedGoogle Scholar
  • 2 Genco A, Lorenzo M, Baglio G. et al. Does the intragastric balloon have a predictive role in subsequent LAP-BAND® surgery? Italian multicenter study results at 5-year follow-up. Surg Obes Relat Dis 2014; 10: 474-478
    CrossrefPubMedGoogle Scholar
  • 3 Ponce J, Quebbemann BB, Patterson EJ. Prospective, randomized, multicenter study evaluating study and efficacy of intragastric dual-balloon in obesity. Surg Obes Relat Dis 2013; 9: 290-295
    CrossrefPubMedGoogle Scholar
  • 4 Do TN, Seah TET, Ho KY. et al. Development and testing of a magnetically actuated capsule endoscopy for obesity treatment. PLoS ONE 2016; 11: e0148035
    CrossrefPubMedGoogle Scholar
  • 5 Phee SJ, Wong KJ, Tan SL. et al. Balloon inflating device and a method for inflating a balloon. U.S. Patent 9375554. 28.06.2016
    PubMedGoogle Scholar